Sandy Srinivas
Impact in
- Pulmonary and Respiratory Medicine top 0.1%
- Renal cell carcinoma treatment
- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment
- Oncology top 0.5%
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Renal cell carcinoma treatment 47
- Prostate Cancer Treatment and Research 45
- Prostate Cancer Diagnosis and Treatment 16
- Surgery 43
- Bladder and Urothelial Cancer Treatments 36
- Urinary and Genital Oncology Studies 8
- Co-authors
- Toni K. Choueiri (21 shared papers)Lauren C. Harshman (20 shared papers)Ulka N. Vaishampayan (17 shared papers)Sumanta Kumar Pal (18 shared papers)Daniel Y.C. Heng (18 shared papers)Brian I. Rini (18 shared papers)Jae‐Lyun Lee (12 shared papers)Lori Anne Wood (15 shared papers)
- Journals
- Journal of the National Comprehensive Cancer Network (17 papers)European Urology (15 papers)Journal of Clinical Oncology (12 papers)Clinical Genitourinary Cancer (11 papers)Cancer (8 papers)
- Partner nations
- United StatesCanadaSouth Korea
In The Last Decade
Sandy Srinivas
162 papers receiving 17.7k citations
Sandy Srinivas's Hit Papers
Peers
Comparison fields: 5 of 143
- Pulmonary and Respiratory Medicine 8.1k
- Oncology 5.6k
- Cancer Research 2.0k
- Surgery 4.6k
- Immunology 1.4k
Countries citing papers authored by Sandy Srinivas
This map shows the geographic impact of Sandy Srinivas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandy Srinivas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandy Srinivas more than expected).
Fields of papers citing papers by Sandy Srinivas
This network shows the impact of papers produced by Sandy Srinivas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandy Srinivas. The network helps show where Sandy Srinivas may publish in the future.
Co-authors
The 25 scholars most cited alongside Sandy Srinivas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 164 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial Hit paper breakdown → | 2016 | 3043 |
| 2 | Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial Hit paper breakdown → | 2016 | 1811 |
| 3 | Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology Hit paper breakdown → | 2019 | 1263 |
| 4 | Prostate Cancer Hit paper breakdown → | 2010 | 783 |
| 5 | Efficacy and Safety of Durvalumab in Locally Advanced or Metastatic Urothelial Carcinoma Hit paper breakdown → | 2017 | 737 |
| 6 | Prostate Cancer, Version 1.2016 Hit paper breakdown → | 2016 | 568 |
| 7 | NCCN Guidelines Insights: Prostate Cancer, Version 1.2021 Hit paper breakdown → | 2021 | 416 |
| 8 | Phase II and Biomarker Study of the Dual MET/VEGFR2 Inhibitor Foretinib in Patients With Papillary Renal Cell Carcinoma Hit paper breakdown → | 2012 | 398 |
| 9 | Cabozantinib in Patients With Advanced Prostate Cancer: Results of a Phase II Randomized Discontinuation Trial Hit paper breakdown → | 2012 | 378 |
| 10 | Prostate Cancer, Version 4.2023, NCCN Clinical Practice Guidelines in Oncology Hit paper breakdown → | 2023 | 363 |
| 11 | Cytoreductive Nephrectomy in Patients with Synchronous Metastases from Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium Hit paper breakdown → | 2014 | 359 |
| 12 | The International Metastatic Renal Cell Carcinoma Database Consortium model as a prognostic tool in patients with metastatic renal cell carcinoma previously treated with first-line targeted therapy: a population-based study Hit paper breakdown → | 2015 | 320 |
| 13 | 2014 | 284 | |
| 14 | EV-101: A Phase I Study of Single-Agent Enfortumab Vedotin in Patients With Nectin-4–Positive Solid Tumors, Including Metastatic Urothelial Carcinoma Hit paper breakdown → | 2020 | 276 |
| 15 | 2013 | 269 | |
| 16 | 2007 | 259 | |
| 17 | 2013 | 214 | |
| 18 | Enfortumab Vedotin Plus Pembrolizumab in Previously Untreated Advanced Urothelial Cancer Hit paper breakdown → | 2022 | 213 |
| 19 | 2012 | 212 | |
| 20 | Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial Hit paper breakdown → | 2022 | 210 |
About Sandy Srinivas
Sandy Srinivas is a scholar working on Pulmonary and Respiratory Medicine, Surgery, Oncology, Cancer Research and Radiology, Nuclear Medicine and Imaging, having authored 164 papers that have together received 18.1k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (47 papers), Prostate Cancer Treatment and Research (45 papers), Bladder and Urothelial Cancer Treatments (36 papers), Prostate Cancer Diagnosis and Treatment (16 papers), Cancer Genomics and Diagnostics (9 papers), Radiopharmaceutical Chemistry and Applications (8 papers), Urinary and Genital Oncology Studies (8 papers) and Renal and related cancers (8 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (8.1k citations), Oncology (5.6k citations), Cancer Research (2.0k citations), Surgery (4.6k citations) and Immunology (1.4k citations). Sandy Srinivas has collaborated with scholars based in United States, Canada and South Korea. Frequent co-authors include Toni K. Choueiri, Lauren C. Harshman, Ulka N. Vaishampayan, Sumanta Kumar Pal, Daniel Y.C. Heng, Brian I. Rini, Jae‐Lyun Lee, Lori Anne Wood, Frede N. Donskov and Sun Young Rha. Their work appears in journals such as Journal of the National Comprehensive Cancer Network, European Urology, Journal of Clinical Oncology, Clinical Genitourinary Cancer and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.